Topic Editors

1. Department of Cancer Biology and Genetics, The Ohio State University College of Medicine, Columbus, OH 43210, USA
2. Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH 43210, USA
Department of Microbiology, Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, UK

Epstein-Barr Virus Disease Mechanisms and Therapeutic Strategies

Abstract submission deadline
closed (30 January 2023)
Manuscript submission deadline
closed (30 April 2023)
Viewed by

Topic Information

Dear Colleagues,

Epstein–Barr virus (EBV) infects a significant percentage (>95%) of the population and establishes a persistent infection. However, most of these infections are asymptomatic. A small but significant number of EBV-positive patients develop a variety of lymphomas, including Burkitt lymphoma, diffuse large-cell B cell lymphoma, classical Hodgkin lymphoma and epithelial malignancies including nasopharyngeal carcinoma and gastric carcinoma. Furthermore, there is increasing evidence that EBV may be a trigger/driver for some autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus, Sjogren’s syndrome and rheumatoid arthritis. Most studies have focused on the potential role of latency-associated gene products in these diseases, but there is accumulating evidence that the products of genes expressed during lytic or abortive-lytic activity may also be involved. This Topic is devoted to exploring the role of how molecules produced during lytic/abortive-lytic replication of EBV may contribute to modifying the host’s immune system in immunocompetent individuals and how the proteins may contribute to the disease process.

Prof. Dr. Marshall Vance Williams
Dr. Jonathan Kerr
Topic Editors


  • Epstein–Barr virus
  • lytic replication
  • innate immunity
  • autoimmunity
  • new therapeutics approaches

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
5.5 8.3 2011 16.9 Days CHF 2700
International Journal of Molecular Sciences
5.6 7.8 2000 16.3 Days CHF 2900
3.7 5.1 2012 16.4 Days CHF 2700
7.8 7.0 2013 19.2 Days CHF 2700
4.7 7.1 2009 13.8 Days CHF 2600 is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with and has built a direct connection between MDPI journals and Authors are encouraged to enjoy the benefits by posting a preprint at prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers

There is no accepted submissions to this Topic at this moment.
Back to TopTop